|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate investments, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Total land | ||||||||||||||||||||
| Buildings, fixtures and improvements | ||||||||||||||||||||
| Total buildings, fixtures and improvements | ||||||||||||||||||||
| Total real estate investments, at cost | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Total less: accumulated depreciation | ||||||||||||||||||||
| Real estate investments, net | ||||||||||||||||||||
| Total real estate investments, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Total operating lease right-of-use assets | ||||||||||||||||||||
| Investment in unconsolidated joint venture | ||||||||||||||||||||
| Total investment in unconsolidated joint venture | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Intangible lease assets, net | ||||||||||||||||||||
| Total intangible lease assets, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Total restricted cash | ||||||||||||||||||||
| Real estate assets held for sale, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Mortgages payable, net | ||||||||||||||||||||
| Total mortgages payable, net | ||||||||||||||||||||
| Credit facility revolver | ||||||||||||||||||||
| Credit facility term loan, net | ||||||||||||||||||||
| Credit facility revolver | ||||||||||||||||||||
| Total credit facility revolver | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Total accounts payable and accrued expenses | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Total operating lease liabilities | ||||||||||||||||||||
| Below-market lease liabilities, net | ||||||||||||||||||||
| Total below-market lease liabilities, net | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Other liabilities, net | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, $0.001 par value, 100,000,000 shares authorized 57,044,714 and 56,314,634 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...